Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04722523
Title A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

hypopharynx cancer

nasal cavity cancer

laryngeal squamous cell carcinoma

paranasal sinus cancer

oropharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

Therapies

Cemiplimab + Cetuximab + Cisplatin + Docetaxel

Carboplatin + Cemiplimab + Cetuximab + Docetaxel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities) Recruiting Basking Ridge New Jersey 07920 United States Details
Memoral Sloan Kettering Monmouth (Limited Protocol Activities) Recruiting Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Recruiting Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Recruiting Commack New York 11725 United States Details
Memoral Sloan Kettering Westchester (Limited Protocol Activities) Recruiting Harrison New York 10604 United States Details
Memorial Sloan - Kettering Cancer Center Recruiting New York New York 10021 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field